Ebola Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: E3AB577A75F7EN
Market Monitor Global

Abstracts

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash, muscular pain, etc. Ebola virus causes haemorrhagic fever which may lead to internal or external bleeding. The symptoms appear anywhere from 2 to 21 days after exposure to Ebola, though the average is 8 to 10 days. Diagnostic tests are now being done by ELISA (Antigen-capture enzyme-linked immunosorbent assay), Polymerase Chain Reaction, Virus Location, IgM Elisa and Immunohistochemistry testing. Few vaccines and medical treatments for Ebola are in pipeline and due to the absence of effective treatments, the pharmaceutical companies now have big opportunities in the market globally. As per WHO, several care rehydration methods are adopted with fluid injection orally and other treatments are also taken care of which improves the survival rate. Top drug companies such as Hemispherx Biopharma, Biochryst Pharmaceuticals, Nano Vircides, Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceuticals are among the key players in the global Ebola treatment market and are conducting trials on a set of experimental drugs.

This report contains market size and forecasts of Ebola Treatment in Global, including the following market information:

Global Ebola Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Ebola Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vaccine (Under Trials) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Ebola Treatment include Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, NanoViricides, NewLink Genetics, Chimerix and Sarepta Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ebola Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Ebola Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Ebola Treatment Market Segment Percentages, by Type, 2021 (%)

• Vaccine (Under Trials)
• Drugs (Under Trials)

Global Ebola Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Ebola Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Ambulatory Surgery Centres
• Specialized Clinics
• Army Camps (Veteran Facilities)

Global Ebola Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Ebola Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Ebola Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Ebola Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Arbutus Biopharma
• GlaxoSmithKline
• Johnson & Johnson Services
• Hemispherx Biopharma
• BioCryst Pharmaceuticals
• NanoViricides
• NewLink Genetics
• Chimerix
• Sarepta Therapeutics
• Mapp Biopharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Ebola Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Ebola Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EBOLA TREATMENT OVERALL MARKET SIZE

2.1 Global Ebola Treatment Market Size: 2021 VS 2028
2.2 Global Ebola Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Ebola Treatment Players in Global Market
3.2 Top Global Ebola Treatment Companies Ranked by Revenue
3.3 Global Ebola Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ebola Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Ebola Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ebola Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Ebola Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Ebola Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Ebola Treatment Market Size Markets, 2021 & 2028
  4.1.2 Vaccine (Under Trials)
  4.1.3 Drugs (Under Trials)
4.2 By Type - Global Ebola Treatment Revenue & Forecasts
  4.2.1 By Type - Global Ebola Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Ebola Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Ebola Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Ebola Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Ambulatory Surgery Centres
  5.1.4 Specialized Clinics
  5.1.5 Army Camps (Veteran Facilities)
5.2 By Application - Global Ebola Treatment Revenue & Forecasts
  5.2.1 By Application - Global Ebola Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Ebola Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Ebola Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Ebola Treatment Market Size, 2021 & 2028
6.2 By Region - Global Ebola Treatment Revenue & Forecasts
  6.2.1 By Region - Global Ebola Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Ebola Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Ebola Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Ebola Treatment Revenue, 2017-2028
  6.3.2 US Ebola Treatment Market Size, 2017-2028
  6.3.3 Canada Ebola Treatment Market Size, 2017-2028
  6.3.4 Mexico Ebola Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Ebola Treatment Revenue, 2017-2028
  6.4.2 Germany Ebola Treatment Market Size, 2017-2028
  6.4.3 France Ebola Treatment Market Size, 2017-2028
  6.4.4 U.K. Ebola Treatment Market Size, 2017-2028
  6.4.5 Italy Ebola Treatment Market Size, 2017-2028
  6.4.6 Russia Ebola Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Ebola Treatment Market Size, 2017-2028
  6.4.8 Benelux Ebola Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Ebola Treatment Revenue, 2017-2028
  6.5.2 China Ebola Treatment Market Size, 2017-2028
  6.5.3 Japan Ebola Treatment Market Size, 2017-2028
  6.5.4 South Korea Ebola Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Ebola Treatment Market Size, 2017-2028
  6.5.6 India Ebola Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Ebola Treatment Revenue, 2017-2028
  6.6.2 Brazil Ebola Treatment Market Size, 2017-2028
  6.6.3 Argentina Ebola Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Ebola Treatment Revenue, 2017-2028
  6.7.2 Turkey Ebola Treatment Market Size, 2017-2028
  6.7.3 Israel Ebola Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Ebola Treatment Market Size, 2017-2028
  6.7.5 UAE Ebola Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Arbutus Biopharma
  7.1.1 Arbutus Biopharma Corporate Summary
  7.1.2 Arbutus Biopharma Business Overview
  7.1.3 Arbutus Biopharma Ebola Treatment Major Product Offerings
  7.1.4 Arbutus Biopharma Ebola Treatment Revenue in Global Market (2017-2022)
  7.1.5 Arbutus Biopharma Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Ebola Treatment Major Product Offerings
  7.2.4 GlaxoSmithKline Ebola Treatment Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Johnson & Johnson Services
  7.3.1 Johnson & Johnson Services Corporate Summary
  7.3.2 Johnson & Johnson Services Business Overview
  7.3.3 Johnson & Johnson Services Ebola Treatment Major Product Offerings
  7.3.4 Johnson & Johnson Services Ebola Treatment Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Services Key News
7.4 Hemispherx Biopharma
  7.4.1 Hemispherx Biopharma Corporate Summary
  7.4.2 Hemispherx Biopharma Business Overview
  7.4.3 Hemispherx Biopharma Ebola Treatment Major Product Offerings
  7.4.4 Hemispherx Biopharma Ebola Treatment Revenue in Global Market (2017-2022)
  7.4.5 Hemispherx Biopharma Key News
7.5 BioCryst Pharmaceuticals
  7.5.1 BioCryst Pharmaceuticals Corporate Summary
  7.5.2 BioCryst Pharmaceuticals Business Overview
  7.5.3 BioCryst Pharmaceuticals Ebola Treatment Major Product Offerings
  7.5.4 BioCryst Pharmaceuticals Ebola Treatment Revenue in Global Market (2017-2022)
  7.5.5 BioCryst Pharmaceuticals Key News
7.6 NanoViricides
  7.6.1 NanoViricides Corporate Summary
  7.6.2 NanoViricides Business Overview
  7.6.3 NanoViricides Ebola Treatment Major Product Offerings
  7.6.4 NanoViricides Ebola Treatment Revenue in Global Market (2017-2022)
  7.6.5 NanoViricides Key News
7.7 NewLink Genetics
  7.7.1 NewLink Genetics Corporate Summary
  7.7.2 NewLink Genetics Business Overview
  7.7.3 NewLink Genetics Ebola Treatment Major Product Offerings
  7.7.4 NewLink Genetics Ebola Treatment Revenue in Global Market (2017-2022)
  7.7.5 NewLink Genetics Key News
7.8 Chimerix
  7.8.1 Chimerix Corporate Summary
  7.8.2 Chimerix Business Overview
  7.8.3 Chimerix Ebola Treatment Major Product Offerings
  7.8.4 Chimerix Ebola Treatment Revenue in Global Market (2017-2022)
  7.8.5 Chimerix Key News
7.9 Sarepta Therapeutics
  7.9.1 Sarepta Therapeutics Corporate Summary
  7.9.2 Sarepta Therapeutics Business Overview
  7.9.3 Sarepta Therapeutics Ebola Treatment Major Product Offerings
  7.9.4 Sarepta Therapeutics Ebola Treatment Revenue in Global Market (2017-2022)
  7.9.5 Sarepta Therapeutics Key News
7.10 Mapp Biopharmaceutical
  7.10.1 Mapp Biopharmaceutical Corporate Summary
  7.10.2 Mapp Biopharmaceutical Business Overview
  7.10.3 Mapp Biopharmaceutical Ebola Treatment Major Product Offerings
  7.10.4 Mapp Biopharmaceutical Ebola Treatment Revenue in Global Market (2017-2022)
  7.10.5 Mapp Biopharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Ebola Treatment Market Opportunities & Trends in Global Market
Table 2. Ebola Treatment Market Drivers in Global Market
Table 3. Ebola Treatment Market Restraints in Global Market
Table 4. Key Players of Ebola Treatment in Global Market
Table 5. Top Ebola Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Ebola Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Ebola Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Ebola Treatment Product Type
Table 9. List of Global Tier 1 Ebola Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ebola Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Ebola Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Ebola Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Ebola Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Ebola Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Ebola Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Ebola Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Ebola Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Ebola Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Ebola Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Ebola Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Ebola Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Ebola Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Ebola Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Ebola Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Ebola Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Ebola Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Ebola Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Ebola Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Ebola Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Arbutus Biopharma Corporate Summary
Table 31. Arbutus Biopharma Ebola Treatment Product Offerings
Table 32. Arbutus Biopharma Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Ebola Treatment Product Offerings
Table 35. GlaxoSmithKline Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Services Corporate Summary
Table 37. Johnson & Johnson Services Ebola Treatment Product Offerings
Table 38. Johnson & Johnson Services Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Hemispherx Biopharma Corporate Summary
Table 40. Hemispherx Biopharma Ebola Treatment Product Offerings
Table 41. Hemispherx Biopharma Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 42. BioCryst Pharmaceuticals Corporate Summary
Table 43. BioCryst Pharmaceuticals Ebola Treatment Product Offerings
Table 44. BioCryst Pharmaceuticals Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 45. NanoViricides Corporate Summary
Table 46. NanoViricides Ebola Treatment Product Offerings
Table 47. NanoViricides Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 48. NewLink Genetics Corporate Summary
Table 49. NewLink Genetics Ebola Treatment Product Offerings
Table 50. NewLink Genetics Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Chimerix Corporate Summary
Table 52. Chimerix Ebola Treatment Product Offerings
Table 53. Chimerix Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Sarepta Therapeutics Corporate Summary
Table 55. Sarepta Therapeutics Ebola Treatment Product Offerings
Table 56. Sarepta Therapeutics Ebola Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Mapp Biopharmaceutical Corporate Summary
Table 58. Mapp Biopharmaceutical Ebola Treatment Product Offerings
Table 59. Mapp Biopharmaceutical Ebola Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Ebola Treatment Segment by Type in 2021
Figure 2. Ebola Treatment Segment by Application in 2021
Figure 3. Global Ebola Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Ebola Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Ebola Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ebola Treatment Revenue in 2021
Figure 8. By Type - Global Ebola Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Ebola Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Ebola Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Ebola Treatment Revenue Market Share, 2017-2028
Figure 12. US Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Ebola Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Ebola Treatment Revenue Market Share, 2017-2028
Figure 24. China Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Ebola Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Ebola Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Ebola Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Arbutus Biopharma Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Services Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Hemispherx Biopharma Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioCryst Pharmaceuticals Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. NanoViricides Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NewLink Genetics Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Chimerix Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sarepta Therapeutics Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Mapp Biopharmaceutical Ebola Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)